Skip to content

World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis

WHODAS-II for Patients With Symptomatic Lumbar Spinal Stenosis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00480311
Enrollment
200
Registered
2007-05-30
Start date
2007-04-30
Completion date
2011-04-30
Last updated
2011-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Keywords

symptomatic, lumbar spinal stenosis, disability, fear avoidance beliefs, quality of life

Brief summary

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule II), as well as to analyze its correlation with symptomatic lumbar spinal stenosis (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ), and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Interventions

OTHERWHODAS II (World Health Organization Disability Assessment Schedule II)

To determine the measurement characteristics of WHODAS II (World Health Organization Disability Assessment Schedule).

Sponsors

Kovacs Foundation
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients seen for symptomatic lumbar spinal stenosis * With signs of neurogenous claudication * MRI or CAT scan concordant with observed signs * Able to read and write * Have signed the informed consent form

Exclusion criteria

* Central nervous system pathology (with or without treatment) * Diagnosis of rheumatic inflammatory disease or fibromyalgia * Red flags for underlying systemic disease * Criteria for diagnosis of disc herniation * Symptoms suggesting saddle anesthesia, cauda equina, loss of sphincter tone or paraparesis * Motor deficit that progresses or does not improve in 6 weeks

Design outcomes

Primary

MeasureTime frame
Measurement characteristics of WHODAS-IIAt baseline and at 7 days

Secondary

MeasureTime frame
Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in symptomatic lumbar spinal stenosisAt baseline and at 7 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026